Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- ChecktodayChange DetectedRevision updated from v3.3.3 to v3.3.4 on the Record History page for NCT02336815; this is a minor version update with no changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history; the footer now removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the site-wide funding-status banner about government delays. This banner did not affect the study data or the history of this trial record.SummaryDifference0.4%

- Check72 days agoChange DetectedThe screenshots show updates to the record history (additional version entries and status notes) rather than substantive changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference10%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.